These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 24200036)

  • 1. Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy.
    Fugate JE; Kalimullah EA; Hocker SE; Clark SL; Wijdicks EF; Rabinstein AA
    Crit Care; 2013 Nov; 17(6):R264. PubMed ID: 24200036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefepime-induced neurotoxicity: a systematic review.
    Payne LE; Gagnon DJ; Riker RR; Seder DB; Glisic EK; Morris JG; Fraser GL
    Crit Care; 2017 Nov; 21(1):276. PubMed ID: 29137682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefepime-induced neurotoxicity in critically ill patients undergoing continuous renal replacement therapy: beware of dose reduction!
    Honore PM; Spapen HD
    Crit Care; 2015 Dec; 19():455. PubMed ID: 26718619
    [No Abstract]   [Full Text] [Related]  

  • 4. Cefepime neurotoxicity: case report, pharmacokinetic considerations, and literature review.
    Lam S; Gomolin IH
    Pharmacotherapy; 2006 Aug; 26(8):1169-74. PubMed ID: 16863493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible coma secondary to cefepime neurotoxicity.
    Abanades S; Nolla J; Rodríguez-Campello A; Pedro C; Valls A; Farré M
    Ann Pharmacother; 2004 Apr; 38(4):606-8. PubMed ID: 14982986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, Electroencephalographic Features and Prognostic Factors of Cefepime-Induced Neurotoxicity: A Retrospective Study.
    Li HT; Lee CH; Wu T; Cheng MY; Tseng WJ; Chang CW; Hsieh HY; Chiang HI; Lin CY; Chang BL; Lin WR; Lim SN
    Neurocrit Care; 2019 Oct; 31(2):329-337. PubMed ID: 30756319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neurotoxicity and safety of treatment with cefepime in patients with renal failure.
    Sonck J; Laureys G; Verbeelen D
    Nephrol Dial Transplant; 2008 Mar; 23(3):966-70. PubMed ID: 18175786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonconvulsive status epilepticus cases arising in connection with cephalosporins.
    Bora I; Demir AB; Uzun P
    Epilepsy Behav Case Rep; 2016; 6():23-7. PubMed ID: 27408805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefepime neurotoxicity despite renal adjusted dosing.
    Gangireddy VG; Mitchell LC; Coleman T
    Scand J Infect Dis; 2011 Oct; 43(10):827-9. PubMed ID: 21604923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged Cefepime-Induced Neurotoxicity in a Patient with End-Stage Renal Disease.
    Nguyen DD; Lai S
    Am J Case Rep; 2022 Jan; 23():e934083. PubMed ID: 35067669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefepime-Induced Neurotoxicity Presenting with Nonconvulsive Status Epilepticus Admitted as a Stroke Alert.
    Cunningham JM; Sachs KV; Allyn R
    Am J Case Rep; 2020 Mar; 21():e921643. PubMed ID: 32147665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefepime- and cefixime-induced encephalopathy in a patient with normal renal function.
    Capparelli FJ; Diaz MF; Hlavnika A; Wainsztein NA; Leiguarda R; Del Castillo ME
    Neurology; 2005 Dec; 65(11):1840. PubMed ID: 16344542
    [No Abstract]   [Full Text] [Related]  

  • 13. Dosing Cefepime for Renal Function Does Not Completely Prevent Neurotoxicity in a Patient With Kidney Transplant.
    Balderia PG; Chandorkar A; Kim Y; Patnaik S; Sloan J; Newman GC
    J Patient Saf; 2018 Jun; 14(2):e33-e34. PubMed ID: 26102002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing Cefepime Neurotoxicity: A Systematic Review.
    Appa AA; Jain R; Rakita RM; Hakimian S; Pottinger PS
    Open Forum Infect Dis; 2017; 4(4):ofx170. PubMed ID: 29071284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective review of neurotoxicity induced by cefepime and ceftazidime.
    Chow KM; Szeto CC; Hui AC; Wong TY; Li PK
    Pharmacotherapy; 2003 Mar; 23(3):369-73. PubMed ID: 12627936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative myoclonus as the leading symptom in acute cefepime neurotoxicity.
    Zimmermann P; Camenzind D; Beer JH; Tarnutzer AA
    BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33832932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Cefepime on Neurotoxicity Development in Critically Ill Adults With Renal Dysfunction.
    Khan A; DeMott JM; Varughese C; Hammond DA
    Chest; 2020 Jul; 158(1):157-163. PubMed ID: 32147247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefepime is Associated with Acute Encephalopathy in Critically Ill Patients: A Retrospective Case-Control Study.
    Singh TD; O'Horo JC; Day CN; Mandrekar J; Rabinstein AA
    Neurocrit Care; 2020 Dec; 33(3):695-700. PubMed ID: 32613426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cefepime-induced encephalopathy: clinical and electroencephalographic features in seven patients].
    Bragatti JA; Rossato R; Ziomkowski S; Kliemann FA
    Arq Neuropsiquiatr; 2005 Mar; 63(1):87-92. PubMed ID: 15830071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cefepime-induced encephalopathy in patients with renal failure].
    Martín Herrera C; Navarro M
    Nefrologia; 2009; 29(2):181. PubMed ID: 19396333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.